DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trisenox (Arsenic Trioxide) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trisenox (Arsenic Trioxide) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Trisenox side effects in male

Reported by a physician from United Kingdom on 2012-07-12

Patient: male

Reactions: Acute Promyelocytic Leukaemia Differentiation Syndrome, Hypotension, Sudden Death, Respiratory Distress, Haemodialysis, Hypoxic-Ischaemic Encephalopathy, Renal Failure, Sepsis, Cardiac Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Atracurium Besylate
    Start date: 2012-05-15
    End date: 2012-05-16

Lestaurtinib
    Dosage: lestaurtinib (cep-701) or placebo

Trisenox
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-15
    End date: 2012-05-16



Possible Trisenox side effects in male

Reported by a physician from Germany on 2012-07-06

Patient: male, weighing 125.0 kg (275.0 pounds)

Reactions: Acute Promyelocytic Leukaemia Differentiation Syndrome, Hepatotoxicity

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Trisenox
    Dosage: 17.7 milligram;
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-06

Vesanoid
    Dosage: 120 milligram;
    Administration route: Oral
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2012-05-22
    End date: 2012-06-06

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017